163 related articles for article (PubMed ID: 24253178)
1. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
Ganeshan VR; Schor NF
Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
[TBL] [Abstract][Full Text] [Related]
2. p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.
Ganeshan V; Ashton J; Schor NF
Cancer Chemother Pharmacol; 2013 Mar; 71(3):777-87. PubMed ID: 23314735
[TBL] [Abstract][Full Text] [Related]
3. Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells.
Yang YP; Wang S; Li X; Schor NF
Oxid Med Cell Longev; 2016; 2016():7568287. PubMed ID: 26843908
[TBL] [Abstract][Full Text] [Related]
4. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
5. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
Myatt SS; Redfern CP; Burchill SA
Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
[TBL] [Abstract][Full Text] [Related]
7. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
8. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells.
Osone S; Hosoi H; Kuwahara Y; Matsumoto Y; Iehara T; Sugimoto T
Int J Cancer; 2004 Nov; 112(2):219-24. PubMed ID: 15352033
[TBL] [Abstract][Full Text] [Related]
10. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells.
Messner MC; Cabot MC
Cancer Chemother Pharmacol; 2011 Aug; 68(2):477-87. PubMed ID: 21072519
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
[TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
15. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells.
Lovat PE; Corazzari M; Goranov B; Piacentini M; Redfern CP
Ann N Y Acad Sci; 2004 Dec; 1028():81-9. PubMed ID: 15650234
[TBL] [Abstract][Full Text] [Related]
17. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide.
Chen YR; Zhou G; Tan TH
Mol Pharmacol; 1999 Dec; 56(6):1271-9. PubMed ID: 10570055
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
20. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]